Pilot Study of the Efficacy and Safety of Sirolimus in the Treatment of Congenital Hyperinsulinism.
Phase of Trial: Phase I/II
Latest Information Update: 29 Sep 2016
At a glance
- Drugs Sirolimus (Primary)
- Indications Hyperinsulinaemia
- Focus Therapeutic Use
- 15 Sep 2015 Status changed from not yet recruiting to recruiting, as reported by ClinicalTrials.gov.
- 20 Aug 2015 New trial record